Document Detail

In-hospital and nine-month outcome of treatment of coronary bifurcational lesions with sirolimus-eluting stent.
MedLine Citation:
PMID:  15757605     Owner:  NLM     Status:  MEDLINE    
Between April 2002 and May 2004, 174 consecutive patients who underwent percutaneous coronary intervention of bifurcational lesions with sirolimus-eluting stents were identified. Two strategies were used: stenting only 1 branch (group 1S, n = 57) or stenting both branches (group 2S, n = 117). The incidence of major adverse cardiac events was evaluated in the hospital and at 9-month follow-up. There were no statistically significant differences between the 2 groups with regard to the incidence of target lesion revascularization (5.4% vs 8.9%, p = 0.76), target vessel revascularization (5.4% vs 11.1%, p = 0.51), and cumulative major adverse cardiac events (18.9% vs 23.3%, p = 0.76) at 9 months.
Lei Ge; Eleutheria Tsagalou; Ioannis Iakovou; Giuseppe M Sangiorgi; Nicola Corvaja; Flavio Airoldi; Alaide Chieffo; Matteo Montorfano; Iassen Michev; Antonio Colombo
Related Documents :
17195205 - Effectiveness and safety of the sirolimus-eluting stents coated with bioabsorbable poly...
20054765 - In-hospital and mid-term clinical outcomes after percutaneous coronary intervention wit...
20129545 - 3-year clinical follow-up of the xience v everolimus-eluting coronary stent system in t...
18003685 - Commentary: shoot the renals!
479985 - An experimental assessment of macroscopic enzyme techniques for the autopsy demonstrati...
6121935 - Comparative investigation of the effects of metoprolol, propranolol, practolol, and ver...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  The American journal of cardiology     Volume:  95     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2005 Mar 
Date Detail:
Created Date:  2005-03-10     Completed Date:  2005-04-21     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  757-60     Citation Subset:  AIM; IM    
EMO Centro Cuore Columbus and San Raffaele Hospital, Milan, Italy; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angina, Unstable / mortality,  therapy*
Angioplasty, Transluminal, Percutaneous Coronary / methods*
Coronary Angiography
Coronary Artery Disease / mortality,  therapy*
Coronary Restenosis / mortality
Death, Sudden, Cardiac / epidemiology
Follow-Up Studies
Hospital Mortality*
Middle Aged
Myocardial Infarction / mortality,  therapy
Outcome and Process Assessment (Health Care)
Risk Factors
Sirolimus / adverse effects*
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Risks of noncardiac surgery after coronary stenting.
Next Document:  Quality of life in octagenarians after coronary artery bypass grafting.